Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centers for Disease Control and Prevention
With
US Department of Veterans Affairs
This study will seek to enroll every eligible patient enrolled in TBTC Study 23. Consenting patients will be asked to undergo measurements of isoniazid (if receiving), rifabutin and 25-OH desacetyl rifabutin levels at a time point in the study when steady state rifabutin levels are expected to have been achieved (at least two weeks following the start of rifabutin).
